Rui Li

Rui Li

Principal Scientist @ BeiGene

About Rui Li

Rui Li is a Principal Scientist at BeiGene in Shanghai, China, with extensive experience in clinical biomarker discovery and development, and a strong background in immunology and epigenetics research.

Company

Rui Li is currently employed at BeiGene as a Principal Scientist. Located in Shanghai, China, BeiGene is a global, commercial-stage biotechnology company focused on discovering and developing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer.

Title: Principal Scientist

Rui Li holds the position of Principal Scientist at BeiGene. In this role, Rui Li brings extensive expertise in clinical biomarker discovery and development, contributing significantly to the company's research and scientific endeavors. Their responsibilities include leading research projects, mentoring junior scientists, and collaborating with teams to advance the development of innovative treatments.

Education and Expertise

Rui Li earned a Doctor of Philosophy (PhD) in Immunology from the Max Planck Institute of Immunobiology and Epigenetics, where they developed a strong background in immunology and epigenetics. Prior to that, they obtained a Master's degree in Cell Biology and a Bachelor's degree in Biotechnology from the University of Science and Technology of China. Rui Li possesses specialized knowledge in advanced biotechnological techniques and methodologies, and has contributed to multiple research publications in the field of immunology and cell biology.

Professional Background

Before joining BeiGene, Rui Li served as a Clinical Biomarker Scientist at Roche from 2020 to 2022, where they participated in collaborative projects with international research teams. Prior to that, they worked as Scientist I at China Novartis Institutes For Biomedical Research Co., Ltd. from 2019 to 2020, and as Senior Associate Scientist at Janssen (China) Research & Development Center from 2018 to 2019. Rui Li completed their PhD at the Max Planck Institute of Immunobiology and Epigenetics from 2013 to 2018.

Achievements and Recognitions

Rui Li has been actively involved in presenting research findings at several international scientific conferences. During their tenure at Roche, Rui Li received recognition for contributions to biomarker research. In addition to their accomplishments in research, Rui Li is also involved in mentoring junior scientists and researchers at BeiGene, fostering the development of the next generation of scientists.

People similar to Rui Li